[
    [
        {
            "time": "",
            "original_text": "沃森生物：公司目前已有进入临床研究和注册申报阶段的各产品均在按计划正常推进相关工作",
            "features": {
                "keywords": [
                    "临床研究",
                    "注册申报",
                    "正常推进"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司目前已有进入临床研究和注册申报阶段的各产品均在按计划正常推进相关工作",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司H股发行事宜已经公司股东大会审议并通过，已收到中国证监会出具的《行政许可申请受理单》，相关工作在持续推进中",
            "features": {
                "keywords": [
                    "H股发行",
                    "股东大会",
                    "证监会",
                    "持续推进"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司H股发行事宜已经公司股东大会审议并通过，已收到中国证监会出具的《行政许可申请受理单》，相关工作在持续推进中",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司新冠mRNA疫苗临床试验的各项工作在正常推进中",
            "features": {
                "keywords": [
                    "新冠mRNA疫苗",
                    "临床试验",
                    "正常推进"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：公司新冠mRNA疫苗临床试验的各项工作在正常推进中",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司13价肺炎结合疫苗生产、批签发和销售工作均正常开展",
            "features": {
                "keywords": [
                    "13价肺炎结合疫苗",
                    "生产",
                    "批签发",
                    "销售",
                    "正常开展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗销售"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：公司13价肺炎结合疫苗生产、批签发和销售工作均正常开展",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]